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Abstract
Background: Trypanosoma brucei is a unicellular parasite which multiplies in mammals (bloodstream form) and
Tsetse flies (procyclic form). Trypanosome RNA polymerase II transcription is polycistronic, individual mRNAs being
excised by trans splicing and polyadenylation. We previously made detailed measurements of mRNA half-lives in
bloodstream and procyclic forms, and developed a mathematical model of gene expression for bloodstream forms.
At the whole transcriptome level, many bloodstream-form mRNAs were less abundant than was predicted by the model.
Results: We refined the published mathematical model and extended it to the procyclic form. We used the model,
together with known mRNA half-lives, to predict the abundances of individual mRNAs, assuming rapid, unregulated
mRNA processing; then we compared the results with measured mRNA abundances. Remarkably, the abundances of
most mRNAs in procyclic forms are predicted quite well by the model, being largely explained by variations in mRNA
decay rates and length. In bloodstream forms substantially more mRNAs are less abundant than predicted. We list
mRNAs that are likely to show particularly slow or inefficient processing, either in both forms or with developmental
regulation. We also measured ribosome occupancies of all mRNAs in trypanosomes grown in the same conditions as
were used to measure mRNA turnover. In procyclic forms there was a weak positive correlation between ribosome
density and mRNA half-life, suggesting cross-talk between translation and mRNA decay; ribosome density was related
to the proportion of the mRNA on polysomes, indicating control of translation initiation. Ribosomal protein mRNAs in
procyclics appeared to be exceptionally rapidly processed but poorly translated.
Conclusions: Levels of mRNAs in procyclic form trypanosomes are determined mainly by length and mRNA decay,
with some control of precursor processing. In bloodstream forms variations in nuclear events play a larger role in
transcriptome regulation, suggesting aquisition of new control mechanisms during adaptation to mammalian
parasitism.
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Background
Organisms of the family Kinetoplastidea are unicellar flag-
ellated eukaryotes which can be free-living or parasitic.
One of the most remarkable features of Kinetoplastid mo-
lecular biology is the arrangement of protein-coding genes
in polycistronic transcription units [1–4], which precludes
control of transcription at the level of individual mRNAs.
All evidence obtained to date indicates that trancription
initiation is determined by chromatin modification [5].
During exponential growth, differences in initiation be-
tween the different polymerase II transcription units have
not been observed. The only documented polymerase II
control is global down-regulation of initiation upon heat
shock or the attainment of stationary phase; this impacts
open reading frames at the beginning of transcription
units earlier than those at the ends [6]. The lack of tran-
scriptional control at the level of individual genes means
that differences in steady-state gene expression must be
effected post-transcriptionally. The most extensive ana-
lyses of gene expression have been for the African tryp-
anosome Trypanosoma brucei, which is the subject of this
paper. Nearly all studies of in vitro cultured T. brucei
have concentrated on the bloodstream form (similar to
the form that multiplies in mammalian blood) and the
procyclic form (similar to the form that multiplies in
the midgut of Tsetse flies). In T. brucei, the transcrip-
tion units that include the genes encoding major
surface proteins of the bloodstream and procyclic forms
- variant surface glycoproteins and the procyclins - are
important exceptions to the general rule: they are tran-
scribed in a developmentally-regulated fashion by RNA
polymerase I [7].
Individual Kinetoplastid mRNAs are generated from
the precursor by processing (Fig. 1). The capped 5′ end
is generated by trans splicing of a 39 nt, capped “spliced
leader” (SL) [8]. Canonical trans splicing signals consist
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Fig. 1 Gene expression from DNA to mRNA in Trypanosoma brucei. The upper panel is a schematic time-lapse image of a polymerase II complex
progressing along a chromosome. Coding regions are in dark colours and 3′ and 5′ untranslated regions are in lighter colours. The capped
spliced leader is in orange. Kinetic constants for the different processes are indicated and the formulae that comprise the model are shown below
the figure 5′ trans splicing (rate constant k1) and 3′ polyadenylation (rate constant k2) compete with nuclear degradation of the precursor
(rate constant k3) and the 5′ spliced intermediate (rate constant k4). Assuming that the two processes are coupled, the rate constant for 3′
polyadenylation (k2) of mRNA A is expected to equal the rate constant for 5′ trans splicing (k1) of mRNA B, and the same applies for mRNA
and mRNA C (k2 of mRNA B = k1 for mRNA C). Based on the observation that that long mRNAs had unexpectedly low abundances, we
added a factor (α) that incorporates length-dependent precursor degradation into the model [16]. In the analysis described in this paper,
we tested alternative versions of this and used a different factor for PC trypanosomes (see text and Table 1). Finally, there is degradation
of the mature mRNA (rate constant k5). Values for k5 are based on transcriptome-wide decay measurements. In addition, the growth rate
of the cells is included via the specific growth rate μ. The growth rate affects the abundance of every RNA species, as during growth the
pre-existing RNA species get diluted
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of a polypyrimidine tract followed by an AG dinucleo-
tide [9, 10]. Use of splice sites of varying efficiencies -
and choices between alternative sites - are thus the first
potential point for post-transcriptional regulation [8].
The polyadenylation of an mRNA is temporally and
mechanistically linked to downstream trans splicing, and
thus depends on recognition of the downstream trans
splicing signal by the splicing machinery [11–15]. In
some cases, this downstream trans splicing event creates
another protein-coding mRNA; in others, the splicing
can form a non-coding RNA that is subsequently
destroyed. For many mRNAs, both alternatives are pos-
sible, due to the presence of more than one splicing sig-
nal in the region preceding the next gene downstream.
At steady state and with constant transcription, the pro-
cessing rate by itself cannot affect the amount of mature
mRNA that is made: no matter how long it takes, the
mRNA will be made eventually [16]. In fact, though, the
precursor is subject to degradation [17]. So if processing
is slow, the precursor may be destroyed before it can be
processed. Thus processing rates can indeed affect the
amount of mRNA that is made. However, we currently
do not know the extent to which splicing and polyadeny-
lation rates contribute to mRNA levels.
Mature mRNAs are exported to the cytosol, where
they are translated and/or degraded (Fig. 1). There is
much more quantitative information available about
these cytosolic events than there is about events in the
nucleus. Numerous studies have documented differences
in the decay rates of individual mRNAs both at steady
state, and between different life-cycle stages [18]. The
“Silicotryp” project aimed to quantify many aspects of
trypanosome gene expression and metabolism, and to
develop mathematical models that reflected the biology
of the organism [19]. In the context of that project,
using high-throughput cDNA sequencing (RNA-Seq),
we completed transcriptome-wide measurements of
mRNA decay rates in cultured bloodstream and procyc-
lic forms [16]. Half-lives varied from less than 5 min to
more than 4 h (beyond the capacity of the assay), with
medians of 12 min for bloodstream forms and 20 min
for procyclic forms. Levels of individual mRNAs varied
from undetectable to over 100 mRNAs/cell/gene, with
medians of 1.1 (procyclic forms) and 1.5 (bloodstream
forms) [16]. We and others also measured ribosome oc-
cupancy of mRNA by ribosome profiling, finding a range
from tightest possible packing to less than one ribosome
per mRNA [20, 21]. The results thus indicate pervasive
regulation of both mRNA decay and translation.
Mathematical modelling of gene expression can help
us to understand how the kinetics of different steps
influence mRNA levels [22–24]. Our first model of T.
brucei gene expression was made for the mRNAs encod-
ing phosphoglycerate kinase isoforms [17]. The model
consists of a series of differential equations that describe
transcription, mRNA trans splicing, and degradation of
both the mRNA precursor and the mature mRNA
(Fig. 1). For phosphoglycerate kinase, all parameters ex-
cept the transcription rate were measured; the model
then enabled us to estimate the transcription rate for
this polycistronic unit [17]. The availability of accurate
transcriptome-wide mRNA abundance and decay mea-
surements [16] meant that we could test whether the
model that had been developed for phosphoglycerate kin-
ase could be applied transcriptome-wide. To do this, we
simulated ‘virtual’ transcripts, rather than doing one-to-
one comparisons with real individual mRNAs [16]. The
cell division time is known, and we assumed that all genes
are transcribed at the same rate, as estimated from the
phosphoglycerate kinase example. The major unknown
parameter was mRNA processing: for the sake of model-
ling, we therefore allowed this rate to vary within
narrowly-defined limits, determined by a very small num-
ber of published individual measurements. Our initial ana-
lyses revealed that our model gave a distribution that was
very similar to that measured for short mRNAs, but lon-
ger mRNAs had lower steady-state abundances than was
predicted based on their half-lives. We therefore included
length-dependent co-transcriptional degradation of pre-
cursor RNAs in the model [16] (Fig. 1). This is consistent
with the idea that the longer the mRNA spends as a pre-
cursor, the more likely it is to be subjected to nuclear pre-
cursor degradation. The length correction considerably
improved the fit of the model to the data.
A major use of mathematical models is to identify the
existence of unknown factors or parameters. The extent
to which a model fits the data depends on (a) the accuracy
of the model and (b) the accuracy of the data that has
been fed into the model. In our case, one of the most obvi-
ous data deficiencies was the absence, for almost all genes,
of information concerning splicing and polyadenylation
kinetics. We therefore set out to use the model to identify
mRNAs which showed unusually slow, or stage-regulated,
splicing. To do this, we first refined the model for blood-
stream trypanosomes, and adjusted the parameters to
make the model suitable for procyclic trypanosomes.
Then, for each individual mRNA, we predicted the abun-
dance using the known length and decay rate. For three
quarters of procyclic form mRNAs, the predicted and
measured abundances differed by less than a factor of 2.
The comparison thus enabled us to identify the mRNAs
that are less abundant than expected, and are therefore
likely to be poorly processed. In addition, we measured
the ribosome occupancy of mRNAs under exactly the
same conditions as were previously used for the mRNA
decay measurements. The combined results enable us to
assess the roles of mRNA processing, decay and transla-
tion in the developmental regulation of gene expression.
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Methods
Modelling
The gene expression model [16] was reprogrammed in
R-3.1.3 and further optimised as described in the text.
All codes are supplied as Additional files 1, 2, 3, 4, 5, 6,
7 and 8. To match experimental data for individual
genes with the predictions, we used the mRNA half-lives
(in min) and abundances (in number of mRNAs per cell
per gene in the haploid genome) that had been mea-
sured previously [16], and the most recent estimates of
transcript length on TritrypDB (http://tritrypdb.org/tri-
trypdb/, July 2015). For model optimisation, transcripts
with no mapped untranslated regions were excluded.
We restricted the data to “reliable” measurements ac-
cording to the following criteria: (a) The two different
estimates of gene copy number for T. brucei Lister 427
[16, 25] should differ by less than a factor of 2 and
should both exceed 0.5; (b) the error in the half-life esti-
mation (residual mean of squares) must be less than 0.3
[16]; the half-life should be within measurable range (be-
tween 5 min and 120 min for bloodstream forms, and
5–240 min for procyclic forms). For bloodstream forms,
we had two independent abundance measurements [16,
25]; we stipulated that there should be a less than two-
fold difference between them. Three independent mea-
surements were available for procyclic forms; in that
case we stipulated that the relative standard deviation
should be less than 2. All of these criteria are arbitrary,
and could be adjusted. The combined criteria (2-fold
each for the gene copy number and abundance measure-
ments) means that we aimed for a maximum error of 4-
fold in the number of mRNAs per gene. The final re-
stricted gene lists that met our criteria included 4089
genes for bloodstream forms and 3776 genes for procyc-
lic forms (Additional file 9: Table S1). For bloodstream
forms, our attempts to optimise the model were done
with more restricted datasets (see Additional file 9: Table
S1 and legend to Table 1).
The transcription rate and mRNA length factor z were
both optimised using the Nelder-Mead optimization al-
gorithm, in order to most closely mirror the abundance
distribution. As an alternative way to measure the influ-
ence of mRNA length on half-life, we re-calculated it as
follows: (a) we modelled the expected amount of mRNA
without applying any length correction; (b) we divided
the measured mRNA abundance by the modelled abun-
dance from (a); (c) we fitted an optimal curve. All of this
optimisation was done to fit the overall distribution, ra-
ther than for individual genes. Results from the various
models are in Additional file 10: Figure S1, Additional
file 11: Figure S2 and Additional file 12: Figure S3.
Motif searches
Motif searches were done using DREME [26], MEME
[27] and to analyse pyrimidine patterns, a custom script
(Additional file 13). 5′-region comparisons compared 62
Table 1 Parameters used in the different models
BS-A BS-B BS-C BS-D BS-E BS-F PC-A PC-B
a No genes examined 851 851 642 851 851 851 3776 3776
b μ (min−1) Division time 0.0019 (6 h) 0.0019 (6 h) 0.0019 (6 h) 0.0019 (6 h) 0.0019 (6 h) 0.0019 (6 h) 0.0011 (10.5 h) 0.0011 (10.5 h)
c v (molecules.cell−1 .min−1) 0.24 0.24 0.24 0.357 0.278 0.278 0.24 0.234
d k1 0.41 data data 0.41 0.41 data 0.41 0.41
e k2 0.41 0.41 data 0.41 0.41 0.41 0.41 0.41
f Length adjustment α z = 600 z = 600 z = 600 z = 660 § § z = 600 §
g Correlation coefficient (r) 0.59 0.60 0.43 0.59 0.54 0.55 0.66 0.60
The Table shows the parameters used for the various models. See also Fig. 1
a) To optimise the model we chose genes for which we had reliable measurements of both half-life and mRNA abundance. For bloodstream forms, we had
attempted to use RNASeq data to determine the rate at which the sequences immediately upstream of the splice site disappeared, with the hope of using that as
a proxy for the splicing rate [16]. For this form we restricted the dataset to mRNAs that had measured precursor half-times of 1–5 min. For BS-C we narrowed this
evern further, using only genes that also had a similar measurement for the gene immediately downstream. This means that the correlation coefficient for BS-C is
not directly comparable to those for the other BS models
(b) Based on measured growth rates (see also [17])
(c) The transcription rate (v) is influenced by the initiation and elongation rates; since neither has been measured, the transcription rate was originally calculated
for bloodstream forms to obtain the measured steady-state mRNA level for PGKC [17] and this value was used in models BS-A - BS-C. For models BS-D and BS-E
the rate was adjusted to give a better fit for the dataset (BS-D) and for BS-E and BS-F, to give a better fit with the new length adjustment (f). For PC-A the rate
was left the same as in BS-A. For PC-B we multiplied the adjusted rates from BS-E and BS-F by a factor of 0.84, based on the fact that the DNA replication rate in
procyclic forms is 0.84 times that of bloodstream forms [56]
(d) k1 = 0.41 is equivalent to a splicing half-time of 1.7 min. This is based on reliable individual measurements of splicing for 3 mRNAs, which gave estimates of
1–3 min [14, 17, 31]. The “data” are the rates estimated by RNASeq [16] (see (a))
(e) Data for BS-C were from the gene immediately downstream (see (a))
(f) For models with a z value: α = (mRNA_length)/z as used in [16]. For models marked §: α = 1/(20.603 x (mRNA_length-0.461) for bloodstream forms; α = 1/(343.77
x (mRNA_length-0.858) for procyclics. The change in the spliced intermediate over time is:
d([5′ spliced intermediate]/dt) = k1 x [precursor] - (k2 + α k4 + μ) x [5′ spliced intermediate]
(g) Pearson’s correlation coefficient (r) between the abundances predicted for individual RNAs, and the measured abundances of those mRNAs
The mRNA degradation (k5) values for the mRNAs were those measured in [16]. The precursor degradation rates k3 and k4 were always 0.08 (half-life 8 min) which
is the rate of disappearance of the PGKB precursor when splicing is inhibited by Sinefungin in bloodstream forms [17]
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mRNAs that had abundances of less than 0.25-fold the
predicted value in both forms with 723 mRNAs with
abundances of 1.5-fold - 2-fold predicted values. Poly-
pyrimidine tract analysis focused on the 70 nt upstream
of the principal splice acceptor, and to reduce the likeli-
hood of considering mis-annotated sites, we considered
only mRNAs with annotated 5′-UTRs between 10 and
300 nt. To look for 3′-UTR motifs that affect degrad-
ation rates, we tried multiple different categories: for ex-
ample, mRNAs that are very unstable and stabilised by
depletion of XRNA in bloodstream but not procyclic
forms, and vice versa; mRNAs that are stable in all
stages; and various other groupings.
Trypanosome culture and ribosome profiling analysis
Trypanosomes were cultured exactly as described in
[16]. For ribosome profiling, RNA was made using Tri-
zol and trypanosome pellets were snap frozen; both were
shipped on dry ice. Ribosome profiling was done exactly
as described in [20]. To determine mRNA levels, the
mRNA was poly(A) selected, fragmented to pieces of
30–70 nt, then made into cDNA as described previously.
It was not possible to conduct a ribosomal RNA deple-
tion as described previously, because the “ribo-minus”
kit that had been used is no longer available and the
new version is unsuitable for trypanosome RNA. Com-
parative analyses concentrated on a set of genes that
represented each unique open reading frame [9, 16].
To analyse polysomal RNA, trypanosome extracts
were subjected to sucrose density gradient centrifugation
[28]. RNA was prepared from the fractions that were
denser than monosomes; the monosomes; and lighter
fractions. A portion was used for Northern blotting with
the spliced leader as probe, to quantify the proportion of
mRNA in the polysomes. Ribosomal RNA was depleted
from another aliquot by incubation with oligonucleotides
complementary to trypanosome rRNA together with
with RNase H, and the RNA was sequenced as described
previously. Further details of this polysomal RNA ana-
lyses will be published elsewhere.
Alignments were done using custom scripts, as previ-
ously described [28, 29]. Statistical analyses were done in
R or RStudio. To find differences between datasets we
used DeSeq [30]. Plots were made using R and Microsoft
Excel, then re-formatted in Adobe Illustrator.
Results
Adjustments to the gene expression model and
adaptation to procyclic forms
In our previous publication, our model for bloodstream-
form gene expression was used to simulate transcriptome-
wide mRNA abundances, using half-life and mRNA length
distributions that matched the measured values [16]. We
did not, however, attempt to analyse predictions for
individual mRNAs. Before doing that, we decided to
examine various details of the model in order to make
sure that it reflected the data to the best extent possible.
Since we have data for mRNA half-lives, the parameters
that needed to be optimised were the transcription rate,
splicing kinetics, polyadenylation kinetics and the relation-
ship between mRNA length and precursor decay. To opti-
mise the model we compared its output with data for
mRNAs for which we have reliable measurements of gene
copy number, mRNA abundance, mRNA length, and
mRNA half-life. After each model adjustment, we first
compared the predicted population distribution with the
real population distribution. Results are shown in the left-
hand panels of Additional file 10: Figure S1, Additional file
11: Figure S2 and Additional file 12: Figure S3. Next, for
each individual mRNA, we compared the simulated
mRNA abundance with the measured abundance: these
results are in the right-hand panels of Additional file 10:
Figure S1, Additional file 11: Figure S2 and Additional file
12: Figure S3. Table 1 shows the changes made in the dif-
ferent model versions, with Pearson correlation coeffi-
cients at the level of individual mRNAs.
In the next step, we looked at processing in blood-
stream forms. Reliable splicing kinetic measurements are
available for just 3 genes: a half time of 1.7 min for the
PGK precursor in bloodstream forms [17], and similar
values for HSP70 in bloodstream forms [31] and for
alpha and beta tubulin in procyclic forms [14]. We first
used the published bloodstream-form model [16] with
no modifications (Table 1, column BS-A). We inputted
the half-life and mRNA length distributions from 851
genes (for the choice see below), and set splicing and
polyadenylation half-times to 1.7 min. The Pearson cor-
relation coefficient between predicted mRNA abundance
and real abundance, at the level of individual mRNAs,
was 0.59 (Table 1).
In our previous RNASeq analyses, we had attempted
to measure bloodstream-form splicing half-times
transcriptome-wide, using as a surrogate the rate at
which the precursor disappeared [16]. We did not know
whether these measurements had any validity because
the numbers of RNASeq reads from precursors were
low, and many mRNAs have several splice acceptor sites.
Nevertheless, for model optimisation, we focused on 851
genes for which we had estimated splicing half-times of
between 1 and 5 min. We hoped that in this way, we
would be excluding mRNAs with very slow processing,
since this might interfere with model optimisation. In-
stead of using a constant splicing time, we tried inserting
the values for processing kinetics that had been mea-
sured by RNASeq (Table 1, columns BS-B and BS-C;
Additional file 10: Figure S1). The correlation was not
improved relative to BS-A, which confirmed our previ-
ous suspicions that our attempted transcriptome-wide
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measurements of splicing rates for individual genes were
too inaccurate to use in modelling. We therefore de-
cided, for subsequent models, to use a fixed splicing
time of 1.7 min. We started from model BS-A and opti-
mised the transcription rate (v) and the length correc-
tion (z-factor) simultaneously using the Nelder-Mead
optimization function (Table 1, column BS-D; Additional
file 10: Figure S1). This yielded a similar fit to model BS-
A, both for the overall distribution and for individual
mRNAs.
The last parameter to be considered was the relation be-
tween length and abundance. We needed to assess
whether this relationship was more complex than the sim-
ple hyperbolic relation used so far. To obtain an empirical
answer, we plotted abundance against half-life for the 851
genes and fitted the length correction directly. The power
relation that we obtained (see formula in Fig. 1 and notes
to Table 1) fitted the data globally better than the linear
relation used before, but slightly decreased the correlation
between prediction and measurement at the level of indi-
vidual mRNAs (Table 1, columns BS-E and F; Additional
file 11: Figure S2). This adjustment also changed the cal-
culated transcription rate.
Next, we made two different models for procyclics. One,
PC-A, was based on BS-A [16], and for the other (PC-B)
we fitted a length-abundance power relation as for BS-E
and F. We used a longer cell division time, as procyclic
forms grow slower than bloodstream forms. We calcu-
lated the steady-state mRNA levels for 3776 genes with
both models. Comparisons between simulated and real
abundances for both models are in Additional file 12:
Figure S3. Both models fitted the procyclic data consid-
erably better than any of the bloodstream-form models
did for the bloodstream-form data (Table 1, Columns
PC-A and PC-B).
Comparing simulated and real abundances of individual
mRNAs reveals which transcripts are regulated by
processes other than mRNA decay
We used some of the better-performing models to pre-
dict the abundances of all mRNAs for which reliable
half-life and mRNA length data were available. Compari-
sons for individual mRNAs using models PC-A and BS-
D are in Fig. 2; other results are in Additional file 14:
Table S2 and Additional file 11: Figure S2 and
Additional file 12: Figure S3. The fit was strikingly better
for procyclic forms than for bloodstream forms. The
good fit for procyclic forms indicates that the structure
of our model is appropriate. Using model PC-A, 74 % of
all mRNAs had abundances that differed from the pre-
dictions by less than 2-fold, and 96 % differed by less
than 4-fold. Where discrepancies were present, the
mRNAs were usually less abundant than expected. Intri-
guingly, of the 15 mRNAs (0.4 %) that were more than
4-fold more abundant than predicted in procyclic forms,
6 encoded ribosomal proteins, and an additional 6 ribo-
somal protein mRNAs were more than 3-fold more
abundant than predicted. The 20 mRNAs encoding ribo-
somal proteins in the dataset are indicated in cyan in
Fig. 2a; the other mRNAs in this category were too
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stable to allow half-life measurement [16]. The obser-
ved:predicted ratios of this functional class in procyclic
forms were significantly higher than all of the other clas-
ses (p = 0.008 by ANOVA with Holm-Bonferroni correc-
tion). We confirmed that the automatically-calculated
half-lives for the 6 most clearly over-represented mRNAs
were not erroneously short: this was not the case since
the maximal discrepancy was a calculated half life that
was about 20 % shorter than a manually plotted one
(Additional file 15: Figure S4). No other class showed
such a strong bias (Additional file 16: Figure S5). Since
these RNAs are all relatively short we looked to see
whether the same effect was seen using the power rela-
tion length adjustment (model PC-B); in this case, 32
mRNAs were more abundant than predicted and 13 of
them encoded ribosomal proteins (Additional file 12:
Figure S3, Additional file 9: Table S1, sheet 2). This re-
sult suggests that the mRNAs encoding ribosomal pro-
teins are either very rapidly processed, or abnormally
resistant to precursor degradation.
Model BS-D was used to predict the abundances of
the 4088 individual mRNAs with reliable measurements
in bloodstream forms. As we previously noted [16],
many mRNAs were less abundant than expected
(Fig. 2b). Just 3 mRNAs were more than 4 times more
abundant than was predicted by the model, and this
time the ribosomal protein mRNAs did not show un-
usual behaviour. 452 mRNAs were more than 4 times
less abundant than predicted for bloodstream forms, as
opposed to 127 in procyclic forms. A lower than ex-
pected abundance indicates that one or more of the pa-
rameters that was used in the modelling for that gene is
incorrect. The most likely explanation is that the pro-
cessing half-time is longer than 1.7 min, since processing
can be modulated at the level of individual genes. How-
ever, slower transcription or an enhanced susceptibility
to nuclear degradation also must be considered.
To find out which genes showed low abundance only
in one of the life-cycle stages, we selected the 3381 genes
for which reliable measurements for both stages were
available. For each mRNA, we then divided the mea-
sured mRNA amount by the predicted amount. Figure 3
shows a comparison of the ratios for bloodstream and
procyclic forms. For 68 % of the mRNAs, the ratios dif-
fered less than 2-fold, and 94 % differed less than 4-fold.
50 mRNAs were more than 4 times less abundant than
predicted in both forms, 63 were less abundant only in
procyclics, and 265 in bloodstream forms (Additional file
14: Table S2).
We compared the RNAs that were less abundant than
expected with the remainder of the mRNAs. No func-
tional category was significantly enriched, and genes at
the end of transcription units (defined as last three genes
before a transcription stop region) were not over-
represented. If processing were slower than normal, ei-
ther splicing or polyadenylation could be affected. Polya-
denylation sites are too heterogeneous for automated
analysis, but we could analyse the sequences upstream
of the open reading frames and dominant splice acceptor
sites. There were no significant differences between the
groups in the lengths of the polypyrimidine tracts up-
stream of the splice sites, and no enriched 5′-UTR mo-
tifs. In contrast, mRNAs that showed unexpectedly low
abundance either in both forms, or in procyclics only,
had significantly longer annotated 5′-UTRs than those
with “normal” abundance. The transcriptome-wide me-
dian 5′-UTR length was estimated at 130 nt [10]. We
found a median length of 101 nt for mRNAs that were
not under-represented in either stage; 181 nt for mRNAs
that were of low abundance in both forms (Student t-
test probability that the distribution is identical to the
first set was p = 0.001) ; and 144 nt (p = .02) for those
with low abundance in procyclics only. There was no
significant enrichment of upstream open reading frames
in any of the categories. Notably, the median 5′-UTR
length for ribosomal protein mRNAs is 22 nt.
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Fig. 3 Relationship between prediction and measurement for
bloodstream and procyclic forms. For each unique gene considered,
the amount of mRNA that was measured was divided by the
predicted amount, and the log2 of the values for both stages
plotted. BS - bloodstream form, model BS-D; PC - procyclic form,
model PC-A. A value of 0 indicates that the prediction was perfect;
this could however also be true if transcription was faster, and
processing slower, than the values that were set in the model.
Measures above 0 indicate either that a processing half-time is shorter
than 1.7 min, or that the steady-state transcription rate is greater than
the value that was used for the model. values below 0 indicate that the
splicing or polyadenylation half-time is longer than 1.7 min. Spots above
the line “PC = 2xBS” are mRNAs for which the measured/prediction
results was at least 2-fold higher in procyclic than in bloodstream forms;
those below the “BS = 2xPC” line have better processing in bloodstream
forms than in procyclics
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Modelling does not yield evidence for regulation of
polymerase II transcription
There are three sets of experimental evidence that RNA
polymerase II transcribes Kinetoplastid genomes at a
constant rate, independent of the chromosome, tran-
scription unit or individual gene. The most convincing
results are from nuclear run-on experiments done with
Leishmania, but quantitation of such experiments is dif-
ficult because the signals are rather low [3, 4]. Second,
in T. brucei procyclic forms, integration of a reporter
plasmid into four different positions in polymerase II
transcription units, upstream of genes encoding tubulin,
aldolase, actin, and HSP70, yielded similar levels of ex-
pression [32]. Thirdly, bloodstream-form mRNA abun-
dance:half-life ratios across chromosome 10 do not show
obvious differences between transcription units [16].
We decided to use our model to challenge the hypoth-
esis of equal transcription rates quantitatively. We used
data from procyclic forms because overall, the model fits
the data better in this form (Table 1 & Fig. 2b). Using
published histone modification results to find start and
stop sites [5] (TritrypDB.org), we selected transcription
units from chromosomes 9, 10 and 11 that contained at
least 13 genes with “reliable” half-life and abundance
measurements. Starting from model PC-B, we allowed
the transcription rate to vary in order to get an optimal
fit of the results to the data. Interestingly, the resulting
calculated transcription rates varied over nearly an order
of magnitude (Table 2, Additional file 17: Table S3). This
could be due to genuine differences in transcription
rates, or could be a consequence of variations in pro-
cessing across the units.
Next, we examined paired divergent transcription
units that share a common initiation region [10]. If tran-
scription really varies, and the initiation rate is deter-
mined only by histone modifications around the start
sites, then units that share a promoter region should
show similar predicted transcription rates. Contrary to
this expectation, the transcription rates that were fitted
for units sharing an initiation region did not correlate.
There are two possible interpretations of this result. One
possibility is that in divergent transcription units, the
rates of transcription in the two directions are not equal.
The alternative is that by chance, different transcription
units have different average processing rates. Only direct
measurements of transcription can resolve this issue.
Ribosome loading in procyclic forms is affected by the
growth conditions
The original aim of our project was to allow transcriptome-
wide modelling of gene expression from RNA synthesis to
the final steady-state protein level. For this, we needed to
measure translation and protein degradation. Two previ-
ous analyses of translation by ribosome profiling have
revealed very wide differences in mRNA translation effi-
ciencies [20, 21]. To compare models with quantitative
data, however, it is essential that the cellular growth con-
ditions for all measurements should be identical. To ex-
tend our analysis to translation, we therefore cultured
trypanosomes exactly as we had for the measurements of
mRNA decay [16] and subjected samples to ribosome pro-
filing [20]. We analysed three procyclic-form and two
bloodstream-form samples (Additional file 18: Table S4).
Correlations between similar samples were always greater
than 0.96 (not shown).
We first compared the new “Silicotryp” results from
the ribosome profiling with our previous ones (denoted
“Jensen” in Figures and Tables). Overall, the results
correlated well (Fig. 4a, b). After excluding VSG ex-
pression site genes, only 22 open reading frames
showed at least two-fold, statistically significant differ-
ences for bloodstream forms (Additional file 18: Table
S4, sheet 4). This is not surprising since the trypano-
some strain and culture conditions were almost identi-
cal. In contrast, for the procyclic forms 314 genes
showed significant differences (Additional file 18: Table
S4, sheets 5 and 7).
Table 2 Optimised transcription rates for selected polycistronic
units. Rates of transcription were optimised using mRNA half-life
and abundance data to get the best fit, using model PC-B. For
each pair of transcription units, divergent transcription initiates
within a common region
Polycistronic
unit pair
Unit Optimised
Transcription rate
Pearson
correlations (R)
Number
of genes
Tb927_10_p1 1 0.51 0.51 28
2 0.20 0.55 36
Tb927_10_p2 1 0.26 0.73 31
2 0.15 0.66 36
Tb927_10_p3 1 0.26 0.66 30
2 0.15 0.67 34
Tb927_10_p4 1 0.28 0.73 36
2 0.07 0.36 52
Tb927_10_p5 1 0.24 0.66 40
2 0.13 0.67 26
Tb927_11_p1 1 0.05 0.73 27
2 0.20 0.65 41
Tb927_11_p2 1 0.12 0.66 36
2 0.45 0.3 18
Tb927_9_p1 1 0.14 0.81 35
2 0.08 0.59 56
Tb927_9_p2 1 0.43 0.59 37
2 0.03 0.74 13
Tb927_9_p3 1 0.61 0.36 18
2 0.34 0.71 14
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The total numbers of ribosomes per cell that mapped to
each ORF is a measure that combines mRNA level and
ribosome density. Interpretation of the results from pro-
cyclic forms is complicated because there were differences
in several parameters: trypanosome strain, medium com-
position, and cell density. The Jensen results are from
strain TREU927, grown to densities of 5–10 × 106/ml in
SDM79 medium, whereas the Silicotryp [19] results are
for strain Lister 427, grown to densities of 1–2 × 106/ml in
MEM Pros. Metabolites from 10 % serum are present in
both media. MEM Pros has 5 mM proline as an energy
source, with about 500 μM glucose from the foetal calf
serum, whereas SDM79 also contains 10 mM glucose.
MEM Pros contains only adenosine as a purine source,
whereas SDM79 also has guanosine and small amounts of
pyrimidines.
Procyclic forms grown with abundant glucose are
known to convert it mainly to succinate and acetate, with
limited dependence on respiratory complexes II and IV
and the F1 ATPase [33]. Proline catabolism results mainly
in secretion of alanine and glutamate, but succinate is also
subject to complex-II-dependent channelling towards
pyruvate and gluconeogenesis [33]. The differences that
we saw in the two datasets ran contrary to our expecta-
tions. We expected the proline-grown cells to express
more proline dehydrogenase [34], since the mRNA level is
higher [16] but no significant differences were observed in
the ribosome-bound mRNAs for this or any other enzyme
of proline catabolism. Strangely, the proline-dependent
MEM-Pros-grown cells showed lower translation of sev-
eral components involved in mitochondrial electron trans-
port, but greater translation of three proteins involved in
glucose metabolism - hexokinase and two subunits of the
mitochondrial alternative oxidase.
The increased production of several other proteins in
the MEM-Pros grown parasites, such as those involved
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Fig. 4 Ribosome profiling results. a Ribosomes per coding sequence (CDS) per cell, procyclic forms (PC). Our previously published results (labelled
“Jensen”) [20] are compared with the set reported here (labelled “Silicotryp”). b As in (a) but for bloodstream forms (BS). c Developmental regulation:
the numbers of ribosomes per kilobase are compared from bloodstream and procyclic forms. The grey-shaded area indicates impossible densities of
less than 30 nt per ribosome. d The relationship between mRNA half-life and ribosome density for procyclic forms. Only mRNAs with reliable
measurements of abundance and half-life were considered, and impossible ribosome densities were excluded
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in kDNA replication, the kinetochore, and DNA repair
could be linked to lower cell density, rather than
medium composition. This population also had in-
creased translation of adenosine and guanosine kinases,
and of an uncharacterised procyclic-form-specific purine
transporter. Differences in expression of some RNA-
binding proteins might have been responsible for some
of the differences in mRNA abundance or translation.
For example, excess translation of the stress response
regulator ZC3H11 was seen in the MEM-Pros grown
parasites, compatible with the observed higher produc-
tion of HSP83 and mitochondrial HSP60 [35].
Ribosome density does not correlate with mRNA half-life
To calculate ribosome densities, the number of ribo-
somes has to be divided by the mRNA abundance. We
had two alternative datasets for this: the published re-
sults for rRNA-depeted mRNA (sequenced as 300 nt
fragments), and, for bloodstream forms, results from
more highly fragmented (30–70 nt) poly(A) selected
mRNA. (Similar results for 30–70 nt fragments from
procyclic forms showed 3′ bias so were discarded.) The
RNA used for ribosome profiling was from 30 to 70 nt
fragments but was not poly(A) selected. It is well known
that the methods used to remove rRNA, and to build li-
braries, can substantially influence RNASeq results [36–
38] and we too found considerable differences between
rRNA-depleted and poly(A) selected trypanosome tran-
scriptomes [25]. As expected, the new “Silicotryp” reads
for highly fragmented bloodstream form poly(A) +
mRNA correlated quite well with those generated previ-
ously by the same method [20] (Fig. 5a), but less so with
those from rRNA-depleted mRNA (Fig. 5b). Since we
already had half-life results for rRNA-depleted mRNA,
we decided to use those abundances for subsequent
calculations.
Ribosome densities were calculated for bloodstream
forms (Additional file 19: Table S5, sheet 2 column O)
and procyclic forms (Additional file 19: Table S5, sheet 1
column K). For bloodstream forms, only 22 mRNAs had
impossible ribosome densities (less than 30 nt/ribo-
some); for procyclics there were 69 (Fig. 4c). Such results
could be caused by an under-estimation of the number
of mRNAs; read counts can also be inaccurate if a gene
is internally repetitive or part of a multi-gene family.
The “impossible” densities could also be caused by the
fact that we assumed that all ribosomes are engaged in
translation, whereas in fact, a small portion is present as
subunits and we do not know how many monosomes
are bound to mRNA (see Legend to Additional file 19:
Table S5). The ribosome densities given in this paper are
therefore almost certainly over-estimated. The median
ribosome density that we calculated was 3.2/kb for pro-
cyclics and 2.7/kb for bloodstream forms. Most mRNAs
showed similar translation in both stages; 1615 mRNAs
were at least 2-fold better translated in procyclic forms,
and 629 in bloodstream forms (Fig. 4c). As previously
noted [20, 21], there was almost no correlation between
mRNA level and ribosome density (not shown).
When mRNAs were split into broad functional cat-
egories, there was no significant developmental regula-
tion of ribosome density for any category. We also
found few significant differences in ribosome densities
between the categories (Additional file 20: Figure S6). In
bloodstream forms, mRNAs encoding proteins of glu-
cose and glycerol metabolism had significantly higher
ribosome densities than average, with a median of about
130 nt/ribosome. The subset involved in glycolysis were
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closely packed, with only 50 nt/ribosome, and was also
well-translated in procyclics (73 nt/ribosome). Results
for alpha and beta tubulin and actin were similar. Citric
acid cycle and pentose phosphate pathway mRNAs were
also well translated in both forms. Since the citric acid
cycle enzymes show no activity in bloodstream forms, it
is likely that some of these mitochondrially-targeted pro-
teins are degraded after translation, as was observed for
cytochrome c [39]. As previously observed [20], most
mRNAs encoding ribosomal proteins are not particularly
well translated (2.8 ribosomes/kb in procyclics, 1.5 in
bloodstream forms) although they are abundant and very
stable.
The availability of ribosome density and mRNA half-
life measurements for cells grown under identical condi-
tions meant that we could now ask questions about how
the two processes interact. We therefore examined the
hypothesis that packing of ribosomes on the mRNA is
correlated with the mRNA half-life. The correlation be-
tween ribosome density and half-life in procyclic forms
was extremely weak (Fig. 4d, Additional file 19: Table S5,
sheet 3), and there was none for bloodstream forms
(Additional file 19: Table S5, sheet 4). We therefore de-
cided to look at the mRNAs with half-lives that had
been too long to measure using transcription inhibition
and RNASeq. Interestingly, the average density on these
coding regions was 11–13 ribosomes/kb, whereas the
average densities on the mRNAs with measureable half-
lives were 5.2 ribosomes/kb for procyclics and 3.7 ribo-
somes/kb in bloodstream forms. This would be compat-
ible with the idea that dense ribosome packing stabilises
an mRNA, but could also simply indicate that these
mRNAs have been selected for both high stability and
very efficient translation.
Some effects on ribosome loading are passive. A very
unstable mRNA cannot have a high ribosome density
because it takes time for translation to initiate after an
mRNA exits the nucleus [40]. If the mRNA is decapped
first, no initiation will occur. In yeast, the interval be-
tween initiation events varies from 4–233 s, with a me-
dian of 40 s [41]; on average, an mRNA with a half-time
of 5 min and a 40s initiation interval cannot load more
than 7 ribosomes before it is decapped. Those mRNAs
with long open reading frames and short half-lives
would thus be expected to show particularly low ribo-
some densities. There was, however, no correlation be-
tween coding region length and ribosome density, either
for the entire dataset or for mRNAs with half-lives of 5–
6 min. This suggests that sequence-specific regulatory
mechanisms override passive kinetic effects.
In procyclic forms, low average ribosome densities are
partially due to lack of translation initiation
Ribosome profiling measures the average ribosome oc-
cupancy across the mRNA population. A low ribosome
density could mean that a small proportion of mRNAs is
highly translated and the rest are stored; or it could
mean that every mRNA has a low number of ribosomes.
If only half of the mRNAs are translated, but elongation
is slow or ribosomes are stalled, the overall calculation
might give a high average ribosome density. To distin-
guish these possibilities we fractionated polysomes on
sucrose gradients, and measured the levels of each mRNA
in the polysomal, monosomal and free fractions by RNA-
Seq. The proportion of total mRNA in the fractions was
also measured by Northern blotting and hybridisation
with a spliced leader probe. This measurement was used
to normalise the RNASeq data, and the proportion of each
mRNA in the polysomal fraction was calculated. For pro-
cyclic forms, we found a partial correlation between the
proportion of mRNA on polysomes and the ribosome
density (Fig. 6). This suggests that some of the translation
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log scale) is plotted against the proportion of the same mRNA that is in the polysomal fraction. Results for specific functional classes are highlighted in
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regulation is at the level of initiation. We examined this in
more detail for mRNAs encoding some functional protein
classes. For proteins with functions in mRNA processing
(Fig. 6, orange dots), there were on average 5 ribosomes/
kb in the total mRNA, but if we re-calculated this includ-
ing only the fraction of mRNA that is on polysomes, there
were 7 ribosomes/kb. Citric acid cycle mRNAs were
mainly in polysomes and had higher ribosome densities:
on average 22 ribosomes/kb in total, and 29 ribosomes/kb
in polysomal RNA (Fig. 6, pink dots). mRNAs encoding
ribosomal proteins, in contrast, were mostly on polysomes
(Fig. 6a, blue dots) but with an average of only 4 ribo-
somes/kb in polysomal RNA. In contrast, results from
bloodstream forms (Fig. 6b) revealed no correlation be-
tween the percentage of the mRNA on polysomes and the
ribosome density measured by RNA-Seq. This could mean
that bloodstream trypanosome mRNAs show more exten-
sive variations in translation elongation rates than do pro-
cyclic mRNAs.
Discussion
The long-term aim of our project is to explain quantita-
tively the process of trypanosome gene expression from
DNA to protein at steady state. Trypanosomes are a
good model for this because of their polycistronic tran-
scription - which means that we can, at least initially, as-
sume that transcription is constant for all genes at
steady state. The number of steps is also limited. As with
all mathematical models of biological processes, some
steps can be fed with detailed measurements, whereas
for others, parameters have to be modelled to fit the
existing data as well as possible. In the case of the phos-
phoglycerate kinase locus, nearly all parameters could be
measured: cell division time, splicing kinetics, mRNA
and protein levels and half-lives, and ribosome loading.
This allowed the construction of a kinetic model that
could be used to estimate the transcription rate and the
polypeptide elongation rate [17]. This can readily be ex-
tended to other individual genes for which measure-
ments are available [16]. Our ability to extend the model
to the entire proteome has so far been constrained by
technical limitations: we lack proteome-wide measure-
ments of protein abundance and turnover. Conse-
quently, our genome-wide modeling can currently cover
only the steps from the genome to steady-state mRNA
levels. Since the best-measured kinetic parameters are
the cell division time and the mRNA half-lives, we are
able to adjust the model to simulate mRNA abundances,
and then use it to predict variations in the other
parameters.
In this work, we showed that most of the variation in
mRNA abundances in procyclic forms can be predicted
based on differences in mRNA half-life and in length-
dependent precursor degradation. Only 6 % of mRNAs
had abundances in procyclic forms that differed more
than 4-fold from the predicted value, and most of those
were less abundant than expected. This must be because
the mRNA spends longer time as a precursor than is
assumed in the model, resulting in excess precursor
degradation. This could, in turn, happen because tran-
scription elongation, trans splicing, or polyadenylation
are slower than the rates that we fed into the model.
Slower processing seems the more likely explanation.
The processing half-time that we used in the model was
derived from rates that were measured for three very
abundant mRNAs. There is plenty of evidence that spli-
cing efficiencies can be influenced by the sequences
around the splice acceptor site [42–44]. We found that
mRNAs with unexpectedly low abundance in procyclics
had somewhat longer annotated 5′-UTRs than normal.
The presence of an open reading frame downstream of
the splice site is important in splice site choice [43, 44],
so it may be that splice acceptor sites that are further
from the start codon are used less efficiently.
Deviations from the model predictions were much
more marked for bloodstream-form trypanosomes than
for procyclics, implying that developmental regulation of
processing could be biased towards reduced abundance
of mRNAs that are not required in bloodstream forms.
Such notions need to be tested by more accurate mea-
surements of processing kinetics. These measurements
are technically demanding, but our model predicts
which mRNAs are good candidates for such experi-
ments. For example, there are six mitochondrial protein
mRNAs that have similar half-lives in bloodstream and
procyclic forms, but are much less abundant in blood-
stream forms (Additional file 14: Table S2, sheet 2).
There have been several recent reports of trypanosome
factors that can influence trans splicing [45–48] and it
will be interesting to find out whether these target such
mRNAs.
Our ribosome profiling experiments confirmed the
major role of translation control in trypanosomes, with
huge variations between mRNAs in ribosome densities.
Unfortunately these results alone cannot be used to pre-
dict the translation rate [41], since a high ribosome
density could indicate not only high translation, but also
pausing or slow elongation. However, in E. coli and
yeast, ribosome profiling data correlates well with pro-
tein abundance both within and across coding regions,
suggesting that in many cases ribosome profiling ap-
proximates absolute protein production [49]. In procyc-
lics, there was a weak correlation between the ribosome
occupancy of mRNAs and the proportion of the mRNA
that co-migrated with polysomes. This suggests that at
least part of the variation in ribosome density is caused
by regulated translation initiation: some mRNAs are
being translated, whereas others are not. Some of the
Antwi et al. BMC Genomics  (2016) 17:306 Page 12 of 16
variation could be between cells at different cell-cycle
stages. To understand this further it would be interesting
to subject synchronised cell populations, and specific
portions of polysome gradients, to ribosome profiling.
We observed a moderate correlation between mRNA
half-life and ribosome density in procyclic trypanosomes.
There is extensive evidence for cross-talk between trans-
lation and the mRNA decay machinery in yeast; al-
though polysomal mRNAs are substrates for the decay
pathway [50, 51], there are several circumstances under
which mRNAs with poor translation show accelerated
decay [52]. However a correlation between ribosome
density and mRNA half-life does not necessarily mean
that high ribosome densities cause an mRNA to be
stable. It may just be that mRNAs that encode abundant
proteins are selected for both high abundance and effi-
cient translation.
The regulation of ribosomal protein synthesis seems to
be exceptional in at least two ways, especially in procyclic
forms. Most of these mRNAs are too stable to allow a
half-life measurement in our RNASeq analysis. Those with
measurable half-lives, however, were more abundant than
expected in procyclic forms, suggesting either very rapid
processing or unusual resistance to co-transcriptional deg-
radation. The second peculiarity, which has been noted
before [20], is that the ribosomal mRNAs have strikingly
low ribosome densities, although high proportions of
these mRNAs are in polysomes. Why could growing cells
need extremely efficient production of a stable mRNA,
then not use it? Most ribosomal protein mRNA levels are
highest in early G1 [53]; perhaps their translation is also
cell-cycle regulated. Alternatively, or in addition, the sur-
plus mRNA may enable rapid synthesis of extra ribosomes
when trypanosomes move to a new environment. Interest-
ingly, the “exceptionality” of ribosomal protein mRNAs is
not confined to trypanosomes. Ribosomal protein mRNAs
also have low ribosome densities in yeast [54], just as in
trypanosomes, but they also show an interesting peculiar-
ity in mRNA synthesis and decay. Miller et al. studied
measured transcription and mRNA decay rates in yeast,
by in vivo 4-thiouracil labelling followed by RNASeq [23].
They found that in general, mRNA synthesis and decay
rates were not correlated for individual mRNAs. In con-
trast, ribosomal protein genes showed exceptionally high
transcription rates, with a strong correlation between their
rates of mRNA synthesis and degradation.
The comparison between our modelling results and
the data indicate that whereas procyclic-form trypano-
somes rely mainly on mRNA decay to determine mRNA
levels, many mRNAs in bloodstream-form trypanosomes
are subject to an additional layer of regulation. Similarly,
whereas the results for procyclic forms suggest that
translation is often controlled at the level of initiation,
bloodstream-form translation control is more complex.
It is generally thought that mammalian-infective try-
panosomes evolved from an ancestor that infected only
arthropods [55]. Our results suggest that adaptation to
the mammalian environment may have involved the ac-
quisition of novel gene expression control mechanisms
that operate in the nucleus.
Ethics
This study did not include the use of any animals, hu-
man or otherwise, so did not require ethical approval.
Conclusions
Levels of mRNAs in procyclic form trypanosomes are
determined mainly by length and mRNA decay, with
some control of precursor processing. In bloodstream
forms variations in nuclear events play a larger role in
transcriptome regulation, suggesting aquisition of new
control mechanisms during adaptation to mammalian
parasitism.
Availability of supporting data
The polysome gradient data are available under acces-
sion numbers E-MTAB-4558 (bloodstream forms) and
E-MTAB-4555 (procyclic forms). The ribosome profiling
results are at NCBI with bioproject ID PRJNA315042.
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Additional file 9: Table S1. Datasets used for modelling, with results.
Data are taken from [16]. Sheet 1: We chose coding regions for which
there had been no more than 2-fold differences in either copy number,
or mRNA abundances, between 2 different experiments in bloodstream
forms. The error in the half-life measurement in bloodstream forms
(residual sum of squares) was also less than 0.3. Sim = simulated results;
results for model BS-D (columns L & M) were used for the main analyses
but those for BS-A and BS-E are also included in columns R-U. Column P
has the following categories: “1. High”: mRNA amount is at least 4 times
higher than expected; “2. Low”: mRNA amount is at least 4 times less
than expected; 3. Normal: mRNA amount is less than 4 times more or less
than expected. Column Q is like column P except that the boundary is
within 2-fold. Sheet 2: As for sheet 1, but for procyclic forms. In this case
mRNAs were taken for which the standard deviation of 3 abundance
measurements was less than twice the mean. Sim = simulated results;
results for model parameters PC-A (columns L & M) were used for the
main analyses but those for PC-B are also included in columns R&S. Sheet
3: Coding regions from sheet 1 for which there was a measured
bloodstream-form splicing time of less than 5 min; used for testing all
bloodstream-form models except BS-C. Sheet 4: Coding regions from
Sheet 4 for which the next gene downstream also had a measured
splicing time of less than 5 min; used for testing bloodstream-form
model BS-C. (XLSX 1679 kb)
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Additional file 10: Figure S1. Adjustments to the gene expression
model for bloodstream forms. The graphs on the left show mRNA
abundances plotted against their half-lives. Modelled mRNA abundances
are in red, and the real mRNA abundances are in black. The green bar
shows the 95 % confidence interval and blue shadowed area shows the
95 % prediction band. In the graphs on the right, the real mRNA abundances
are plotted against the simulated values for the same half-life and mRNA
length. The values and models used for the predictions are listed in Table 1.
Log2 values were used. (PDF 1371 kb)
Additional file 11: Figure S2. Further adjustments to the gene
expression model for bloodstream forms. Top four panels: The graphs on
the left show mRNA abundances plotted against their half-lives. Modelled
mRNA abundances are in red, and the real mRNA abundances are in
black. The green bar shows the 95 % confidence interval and blue
shadowed area shows the 95 % prediction band. In the graphs on the
right, the real mRNA abundances are plotted against the simulated values
for the same half-life and mRNA length. The values and models used for
the predictions are listed in Table 1. Lower panels: These are the same as
Fig. 2B, except that models BS-A and BS-E were used and log2 values are
shown. (PDF 1142 kb)
Additional file 12: Figure S3. Adjustments to the gene expression
model for procyclic forms. Upper four panels: The graphs on the left
show mRNA abundances plotted against their half-lives. Modelled mRNA
abundances are in red, and the real mRNA abundances are in black. The
green bar shows the 95 % confidence interval and blue shadowed area
shows the 95 % prediction band. In the graphs on the right, the real
mRNA abundances are plotted against the simulated values for the same
half-life and mRNA length. The values and models used for the predictions
are listed in Table 1. Lower panel: This is like Fig. 2a, showing the ribosomal
protein mRNAs, except that the model used is PC-B and log2 values are
shown (PDF 1630 kb)
Additional file 13: Script for polypyrimidine tract analysis (R 2 kb)
Additional file 14: Table S2. Sheet 1: Results for coding regions present
in both sheets 1 and 2 of Additional file 9: Table S1 are compared, using
PC-A and BS-D for modelling. Column “BS ratio/PC ratio” is column M
divided by column H and indicates possible developmental regulation of
processing. Column O: “1. BS low”: mRNA amount is at least 4 times less
than expected in bloodstream forms; “2. PC Low”: mRNA amount is at least
4 times less than expected in procyclic forms; 3. Both low: mRNA amount is
at least 4 times less than expected in both forms; 4. Normal: remaining
genes, except for “5. BS high”: mRNA amount is at least 4 times more than
expected in bloodstream forms. Data for 5′-UTRs and upstream ORFs are
from TritrypDB. Sheet 2: mRNAs that were at least 4 times less abundant
than predicted in bloodstream forms, and more abundant than predicted
procyclic forms. Sheet 3: mRNAs that were at least 4 times less abundant
than predicted in both bloodstream and procyclic forms. Note that columns
Q and R are not independent since each includes the mRNA abundance.
Sheet 4: Statistical analyses. Sequence information was taken from from
TritrypDB. (XLSX 796 kb)
Additional file 15: Figure S4. Accuracy of automatically calculated
half-lives and abundances for mRNAs encoding ribosomal proteins. The
original mRNA decay results for six ribosomal protein mRNAs that were
more than 4 times more abundant than expected in procyclic forms are
shown, as reads per million reads corrected for total mRNA abundance
[16]. The key is on the Figure. The red arrow indicates the half-life that
was calculated in [16] according to [57]. (PDF 423 kb)
Additional file 16: Figure S5. Ratio between observed and predicted
mRNA abundances in procyclic forms, for mRNAs encoding proteins in
different functional categories. The categories were manually assigned
and can be found in the supplementary tables. The box plot indicates
the median with first and third quartile, with whiskers for the 95 %
confidence limits. The ANOVA p-value for ribosomal protein mRNAs was
0.001. (PDF 395 kb)
Additional file 17: Table S3. Transcription rate analysis. Transcription
rates were fitted for genes in individual polycistronic transcription units
that share a common transcription initiation region. The lists of genes
used are in the following sheets. The top sheet also shows calculations
for some other transcription units. (XLSX 43 kb)
Additional file 18: Table S4. Ribosome profiling data. Jensen - data
from [20]; Silicotryp - data from [16] and this paper. All numbers were
suitably rounded after the calculations had been finished. Gene annotation
is partly from tritrypDB and partly manual. Sheet 1: Raw read counts for all
ORFs. RP = ribosome profiling, FR = fragmented poly(A) + RNA. BS =
bloodstream, PC = procyclic. Sheet 2: Reads for the unique gene set of
genes [9], used in subsequent calculations. Sheet 3: DeSeq comparison of
Jensen and Silicotryp results (total ribosome profiling reads per ORF) for
procyclic forms. Sheet 4: DeSeq comparison of Jensen and Silicotryp results
(total ribosome profiling reads per ORF) for bloodstream forms. Sheet 5:
DeSeq comparison of Jensen and Silicotryp results (total fragmented RNA
reads per ORF) for procyclic forms. Sheet 6: DeSeq comparison of Jensen
and Silicotryp results (total fragmented RNA reads per ORF) for bloodstream
forms. Sheet 7: ORFs that showed significant differences in ribosome
profiling reads between the Jensen and Silicotryp datasets. Red are higher
in Silicotryp and blue are lower. Sheet 8: Reads per million calculated for the
unique gene set. Sheet 9: Alignment statistics. rp = ribosome profiling; fr =
fragmented poly(A) + RNA. PC- = procyclic, BS = cultured bloodstream forms.
Sheet 10: Alternative normalisation using EdgeR. (XLSX 7622 kb)
Additional file 19: Table S5. Ribosome density calculations and
comparisons. Sheet 1. Ribosome densities in procyclic forms. The average
number of ribosomes per ORF was calculated as follows. First, we needed
to correct the ribosome profiling results for the gene copy number in the
genome assembly, since during the initial alignments, the reads had
been spread out among all orthologues. Orthologue counts were taken
from TritrypDB. Unexpected numbers were checked against our previous
read alignment data [20], and in some cases manually. Read results for
some gene families (such as amino acid transporters) are unreliable
because related genes show different regulation. The orthologue counts
used are in column D. All RPM were multiplied by the orthologue count
(column H). Numbers of mRNAs per cell [16] were previously calculated
assuming a total of 19,000 non-VSG mRNAs in bloodstream forms, and
43,000 non-EP-procyclin mRNAs/cell in procyclics [17]. There are about
275000 ribosomes per procyclic parasite and 125000 per bloodstream
form [17]. The ribosome densities are calculated using these numbers. In
practice, the densities are likely to be lower. About 5 % of ribosomes are
likely to be on ORFs that were excluded from the analysis (Procyclin, VSG,
ESAGs, and from repetitive elements). Approximately 70 % of all ribosomal
RNA is in polysomes, 20 % is in monosomes and the rest is in subunits (our
unpublished results); we do not know what proportion of the ribosomes in
the monosomal fraction is engaged in translation. Sheet 2. Ribosome
densities in bloodstream forms. Sheet 3. Ribosome densities and half-lives in
procyclic forms, using only the “reliable” values that were chosen for modelling.
Sheet 4. Ribosome densities and half-lives in bloodstream forms, using only
the “reliable” values that were chosen for modelling. (XLSX 2688 kb)
Additional file 20: Figure S6. Ribosome densities for mRNAs encoding
proteins in different functional categories. The categories were manually
assigned and can be found in the supplementary tables. The box plot
indicates the median with first and third quartile, with whiskers for the
95 % confidence limits. Outliers with more than 40 ribosomes per kb were
included in the calculation but are not shown. ANOVA p values were
calculated after removal of impossible ribosome densities (>40/kb); the
uncorrected values are indicated for classes with p < 0.05. (PDF 437 kb)
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